Catalyst Wire Dossier Catalyst Wire Dossier

Sotatercept

sotatercept · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for Sotatercept, covering 2016-09-01 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) [Phase 3]

See pricing